HB 15

  • Delaware House Bill
  • 152nd General Assembly (2023-2024)
  • Introduced in House Mar 19, 2024
  • Passed House Mar 19, 2024
  • Passed Senate Mar 21, 2024
  • Signed by Governor Mar 21, 2024

An Act To Amend Title 18 Of The Delaware Code Relating To Ovarian Cancer.

Abstract

This Act requires all individual, blanket, and group health insurance policies to cover annual ovarian cancer screening tests for women at risk for ovarian cancer. It further expands the scope of monitoring tests available to women subsequent to ovarian cancer treatment.

Bill Sponsors (26)

Votes


Mar 21, 2024

Mar 19, 2024

Actions


Mar 21, 2024

Office of the Governor

Signed by Governor

Senate

Passed By Senate. Votes: 21 YES

Mar 20, 2024

Senate

Reported Out of Committee (Health & Social Services) in Senate with 7 Favorable

  • Committee-Passage
  • Committee-Passage-Favorable
Health & Social Services

Mar 19, 2024

House

Passed By House. Votes: 39 YES 2 ABSENT

House

Amendment HA 1 to HB 15 - Passed In House by Voice Vote

Senate

Assigned to Health & Social Services Committee in Senate

  • Introduction
  • Referral-Committee
Health & Social Services

Mar 14, 2024

House

Amendment HA 1 to HB 15 - Introduced and Placed With Bill

Mar 13, 2024

House

Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits

  • Committee-Passage
  • Committee-Passage-Favorable
Health & Human Development

Feb 29, 2024

House

Introduced and Assigned to Health & Human Development Committee in House

  • Introduction
  • Referral-Committee
Health & Human Development

Bill Text

Bill Text Versions Format
Bill Text PDF HTML
HA 1 to HB 15 HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Delaware General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.